Autopsy report · NCT01449448

Subacromial Injection With Corticosteroid Versus Nonsteroidal Anti-inflammatory Drugs (NSAID) in Shoulder Impingement Syndrome

“PI didn't have time to finish approval process”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Madigan Army Medical Center

Sponsor type

US federal agency

Conditions

Subacromial Impingement Syndrome; Subacromial Bursitis

Interventions

Ketorolac; Triamcinolone

Participants

0

Trials that died the same way

• Study of the Anti-PD-1 Antibody Nivolumab in Combination With Dabrafenib and/or Trametinib
  “PI decided not to proceed” (73% match in meaning)
• Pilot Study Investigating the Use of the ReBuilder to Treat Chemotherapy Induced Peripheral Neuropathy in Patients With Breast Cancer
  “PI decided no longer to pursue” (64% match in meaning)
• Pre-post Spinal Popliteal Block
  “Retrospective study that the PI decided not to proceed with” (63% match in meaning)
• Cross-sectional Study on a Given Day Within the Paris Saint-Joseph Hospital Group
  “The PI decided it.” (59% match in meaning)
• Detecting Early Myocardial Infiltration w/Amyloid & Light Chain Deposition Disease in Multiple Myeloma Subjects
  “PI does not have time to continue study” (57% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.